Lung Cancer Trial, Recruiting NCT07322367 Sponsor: Wake Forest University Health Sciences Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT07322367
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between the ages of 50 and 77 years old
  • People who have smoked at least 20 pack-years (this is a measure of smoking history — confirm with trial site if unsure how to calculate this)
  • People who currently smoke, or who stopped smoking within the last 15 years
  • People who receive their regular primary care within the Atrium Health Wake Forest Baptist health network, meaning they have had at least 1 primary care appointment there in the past 6 months, or at least 2 appointments in the past 18 months, or have a primary care appointment scheduled there within the next 30 days
  • People who have a patient portal account or a cellphone number recorded in their health records at that network
  • People who have a North Carolina address on file in their health records

Who may not be able to join:

  • People whose health records indicate they need an interpreter for a language other than Spanish, as the trial materials are only available in English or Spanish
  • People who have previously been diagnosed with lung cancer
  • People who have had a chest CT scan within the last 12 months
  • People who have significant other health conditions or frailty that would make lung cancer screening unsuitable, based on specific medical guidelines (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Brent Heideman, Jr., MD, Wake Forest Baptist Comprehensive Cancer Center

Phone: 704-355-2000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 March 2026
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of Participants to Complete Lung Screening CT - Primary Effectiveness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov